Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 22
Filtrar
1.
Rev Med Interne ; 37(5): 321-6, 2016 May.
Artículo en Francés | MEDLINE | ID: mdl-26320365

RESUMEN

PURPOSE: Clinical reasoning and treatment challenges within the scope of general practice led to the development of an internal medicine assistance line provided by Nantes University Hospital. The primary outcome of this study was to describe callers' profile, their requests and answers provided. METHODS: A prospective, cross-sectional, observational, descriptive study was undertaken. For each call were identified the calling physician, her/his specialty and work setting, the call's object and adequacy, the answer provided, the time needed to connect with the assistance line, the time devoted by the internal medicine physician to provide an answer to the request, and whether the assistance line prevented a visit to the emergency room. Each calling physician was then called back to obtain demographic and professional characteristics, and data relating to the call and to the assistance line. RESULTS: Sixty-three days were analyzed and 276 calls identified. The 237 identified calling physicians were mainly females (54%, n=93), with a mean age of 46 years, graduated from Nantes University (65%, n=86), practicing ambulatory general medicine (69%, n=164) in Loire-Atlantique department area (82%, n=176) for a mean duration of 15 years. Calls were mostly associated with diagnostic challenges (61%, n=166) concerning clinical issues (57%, n=155). A sole telephone advice was the main type of answer provided (56%, n=147) and a visit to the emergency room was prevented for 17% of calls. CONCLUSION: The assistance line activity is adequate with its missions and seems to facilitate patients' healthcare delivery advocating for the development of similar structures in other units. Improvements relating to the information, availability and physicians' training should be considered.


Asunto(s)
Medicina General , Líneas Directas , Medicina Interna , Telemedicina , Teléfono , Adulto , Anciano , Toma de Decisiones Clínicas/métodos , Estudios Transversales , Enfermedad , Femenino , Francia/epidemiología , Medicina General/métodos , Medicina General/organización & administración , Medicina General/normas , Líneas Directas/estadística & datos numéricos , Humanos , Medicina Interna/métodos , Medicina Interna/organización & administración , Medicina Interna/normas , Masculino , Persona de Mediana Edad , Telemedicina/métodos , Telemedicina/normas
3.
Ann Chir Plast Esthet ; 57(1): 67-71, 2012 Feb.
Artículo en Francés | MEDLINE | ID: mdl-21236542

RESUMEN

We report the case of a patient with mammary implants for 42 years. She presented for three years a change of the general state with clinicobiological demonstrations of indefinite origin, and a progressive bilateral increase of her mammary volume until it became exceptional. The surgery of explantation allowed the retreat of two masses of almost 6kg. The analysis did not put in evidence any malignant process but confirmed that it was about prostheses in polyethylene. In one year of recession, a considerable improvement of her general state was observed.


Asunto(s)
Implantes de Mama/efectos adversos , Caquexia/etiología , Mamoplastia/efectos adversos , Mastectomía , Polietilenos/efectos adversos , Anciano , Remoción de Dispositivos , Diagnóstico Diferencial , Femenino , Humanos , Mamoplastia/métodos , Enfermedades Raras , Reoperación , Resultado del Tratamiento
4.
Rev Med Interne ; 28(6): 363-70, 2007 Jun.
Artículo en Francés | MEDLINE | ID: mdl-17275968

RESUMEN

BACKGROUND: Inflammatory involvement of extracranial large-sized arteries occurs in 10-20% of patients with giant cell (temporal) arteritis. Aortic involvement may reveal giant cell arteritis or occur as a late-onset complication, and represents one of the most serious manifestation of the disease with the risk of aortic dissection and/or aneurysm rupture. The thoracic aorta is more frequently involved but abdominal aortitis may also occur in giant cell arteritis. To date, few data are available about abdominal aorta changes at the initial stage of giant cell arteritis. PATIENTS AND METHODS: This prospective monocentric study was conducted between May 1998 and May 2002, and included 30 consecutive patients with biopsy-proven giant cell arteritis. Standard clinical and biological data were collected. Each patient underwent an abdominal aortic Doppler-sonography that looked for aneurysm, ectasia, thickening of the vascular wall, and hypoechoic halo around the aorta. RESULTS: Among the 30 patients of this study (25 women, 5 men, mean age 68.5 years), 4 (13%) had an abdominal aortic aneurysm, with a low diameter (23 to 27 mm), measuring 2 to 5.5 cm in length. A vascular wall thickening superior or equal to 3 mm was noted in 17 patients (68%). A 4 to 8 mm periaortic hypoechoic halo was found in 10 patients (33%). This halo was present in 3 out of the 4 patients with aneurysm. CONCLUSION: Aortic involvement is a potentially serious complication of giant cell arteritis. The question of a systematic screening of this complication remains open to discussion. Our study shows that Doppler sonography may detect morphological abnormalities on the abdominal aorta at the initial stage of giant cell arteritis. These abnormalities comprise mild aneurysms, thickening of the vascular wall and periaortic halo, which could correspond to inflammatory locations of the disease. Complementary studies are needed to assess their specificity and their seriousness.


Asunto(s)
Aorta Abdominal/diagnóstico por imagen , Arteritis de Células Gigantes/diagnóstico por imagen , Anciano , Anciano de 80 o más Años , Proteína C-Reactiva/metabolismo , Diagnóstico Diferencial , Femenino , Humanos , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Ultrasonografía Doppler
5.
Ann Rheum Dis ; 66(4): 554-6, 2007 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-17068062

RESUMEN

BACKGROUND: Rare cases of vasculitis restricted to the lower limbs have been reported, but the characteristics, outcome and response to treatment of this entity are not well known. OBJECTIVE: To describe the clinical, complementary examinations and response to treatment of this rare entity in the first retrospective series, and to compare data with historical pooled cases. METHODS: Retrospective analysis of all biopsy-proven cases observed over a 10-year period in four French tertiary medical units. Diagnosis of vasculitis restricted to the lower limb required the absence of any clinical symptom and complementary test finding, suggesting major extramuscular visceral involvement. RESULTS: 11 patients were included. Vasculitis restricted to the lower limb was associated with disabling muscle pain of the calves. Fever was present in 50% of cases; ankle arthralgia in 50% and skin involvement in 40%. MRI was the cornerstone of the diagnosis, showing hyperintense signal in T2 weight and in T1 weight after gadolinium injection. MRI findings correlated well with clinical outcome and were useful in guiding biopsy. Muscle biopsy was consistent with a polyarteritis nodosa-type vasculitis in only 40% cases, whereas a leucocytoclastic vasculitis was seen for all other cases. Treatment with corticosteroids was effective in all cases, but there were relapses requiring immunosuppressive agents in 54% of cases. CONCLUSION: Vasculitis of the calf muscles must be considered for patients with calf pain and with a biological inflammatory syndrome.


Asunto(s)
Pierna/irrigación sanguínea , Vasculitis/diagnóstico , Adulto , Anciano , Anciano de 80 o más Años , Femenino , Fiebre/etiología , Humanos , Dermatosis de la Pierna/diagnóstico , Imagen por Resonancia Magnética , Masculino , Persona de Mediana Edad , Músculo Esquelético/irrigación sanguínea , Enfermedades Musculares/etiología , Dolor/etiología , Flujo Sanguíneo Regional , Estudios Retrospectivos , Enfermedades Cutáneas Vasculares/diagnóstico , Vasculitis/complicaciones , Vasculitis/patología
6.
Rev Med Interne ; 27(4): 276-84, 2006 Apr.
Artículo en Francés | MEDLINE | ID: mdl-16530889

RESUMEN

PURPOSES: Ten to fifteen percent of granulomatous hepatitis are idiopathic. If symptoms like prolonged fever are present, empirical treatment is discussed. The goal of this study is to describe the empirical treatment proposed in this situation by French specialists of internal medicine. METHODS: We conducted a practice investigation among the French national society of internal medicine (SNFMI), using an anonymous questionnaire that related a case of idiopathic granulomatous hepatitis. This questionnaire was proposed to all French internists present at the SNFMI congress in June and December 2004. French specialists of internal medicine had to answer if they would prescribe an empirical treatment and if so, to specify this treatment. RESULTS: Thirty-six French specialists of internal medicine answered to the questionnaire. In the proposed situation, 89% of them initiate an empirical treatment. In 18/36 cases (50%), a first-line anti-tuberculosis empirical treatment is proposed (quadritherapy in 11 cases). In 7 cases (19%), an empirical treatment with prednisone, 0.4 mg/kg/d (N=1) and 1 mg/kg/d (N=6), would be prescribed. Seven internists (19%) would prescribe an empirical treatment with cyclins at the dose of 100 to 400 mg/d. Median duration of the empirical treatment would be 28 days (range: 8-252d). The evaluation parameters mentionned are: fever (69%), weight (59%), seric level of C-reactive protein (59%), and liver biology (53%). In case of failure of first-line empirical treatments, 69% of all questionned internists prescribe a second-line treatments: prednisone at the dose of 0.4 to 2 mg/kg/d (72%), anti-tuberculosis treatments (16%), cyclins 200 mg/d (12%), with a median duration of 28 days. Seven internists (19%) propose to combine two empirical treatments. DISCUSSION: Faced with a problem of idiopathic granulomatous hepatitis, French internists questionned propose four therapeutics options: no treatment, anti-tuberculosis treatment, cyclins or steroids treatment. First-line anti-tuberculosis treatment is a coherent proposition regarding to the high prevalence of tuberculosis. There are only few data available concerning empirical treatment with steroids or cyclins. Specific proposition of such empirical treatments should be defined. CONCLUSIONS: The management of idiopathic granulomatous hepatitis is difficult. Our study shows that therapeutics practices of French internists are heterogenous. The main proposition consists in a first-line anti-tuberculosis empirical treatment, that has to be evaluated after four weeks, and switched with steroids (prednisone, 1 mg/Kg/d) in case of failure. This study is not an expert proposition but contributes to suggest clinical practice guidelines for a rare, complex, heterogenous, and typically internist situation.


Asunto(s)
Granuloma/tratamiento farmacológico , Hepatitis/tratamiento farmacológico , Tuberculoma/tratamiento farmacológico , Corticoesteroides/administración & dosificación , Corticoesteroides/uso terapéutico , Adulto , Antibacterianos/administración & dosificación , Antibacterianos/uso terapéutico , Antiinflamatorios/administración & dosificación , Antiinflamatorios/uso terapéutico , Antituberculosos/administración & dosificación , Antituberculosos/uso terapéutico , Biopsia , Quimioterapia Combinada , Francia , Granuloma/diagnóstico , Granuloma/patología , Hepatitis/diagnóstico , Hepatitis/patología , Hepatomegalia/diagnóstico , Hepatomegalia/patología , Humanos , Medicina Interna , Hígado/patología , Masculino , Persona de Mediana Edad , Guías de Práctica Clínica como Asunto , Prednisona/administración & dosificación , Prednisona/uso terapéutico , Sociedades Médicas , Encuestas y Cuestionarios , Factores de Tiempo , Tuberculoma/diagnóstico , Tuberculoma/patología
8.
J Rheumatol ; 19(11): 1733-4, 1992 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-1491392

RESUMEN

The coexistence of giant cell arteritis (GCA) and autoimmune thyroid diseases has been suggested. In our prospective study of 39 patients with GCA, we measured autoantibodies and thyroid function and compared the results to those of a control group. No statistical difference was found. Our conclusions differ from those of other authors.


Asunto(s)
Autoanticuerpos/análisis , Arteritis de Células Gigantes/complicaciones , Arteritis de Células Gigantes/inmunología , Tiroglobulina/análisis , Tiroiditis Autoinmune/complicaciones , Tiroiditis Autoinmune/inmunología , Anciano , Femenino , Arteritis de Células Gigantes/epidemiología , Humanos , Masculino , Estudios Prospectivos , Glándula Tiroides/fisiología , Tiroiditis Autoinmune/epidemiología
9.
AIDS ; 5(6): 729-33, 1991 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-1883545

RESUMEN

Endocrine function was prospectively evaluated in 98 patients (73 men and 25 women) infected by HIV in various stages of illness: Centers for Disease Control groups II (19), III (20), IVA and IVC2 (27), IVC1 and IVD (32). Testing included baseline and post-stimulation evaluation of gonadal, thyroidal, and adrenal axes. Although adrenal function was within normal values in most cases, with no differences between patient groups, nine out of 98 patients had either a low baseline or post-stimulation serum cortisol, cytomegalovirus adrenalitis being suspected in two cases. Mineralocorticoid response was normal in all individuals. The main abnormalities were sick euthyroid syndrome with low tri-idothyronine and/or thyroxine in 16% of patients and hypotestosteronemia in 29% of men with AIDS. These abnormalities, related to a functional deficiency of the hypothalamic-pituitary axis, were highly correlated with the degree of illness, i.e. weight loss and low CD4+ cell count. It was concluded that endocrine dysfunction in HIV-infected patients is rarely of clinical significance, that it is related more to cachexia and advanced disease than to HIV or opportunistic infections, and that it could serve as a prognostic marker.


Asunto(s)
Síndrome de Inmunodeficiencia Adquirida/fisiopatología , Glándulas Suprarrenales/fisiopatología , Infecciones por VIH/fisiopatología , Testículo/fisiopatología , Glándula Tiroides/fisiopatología , Síndrome de Inmunodeficiencia Adquirida/complicaciones , Adolescente , Adulto , Anciano , Síndromes del Eutiroideo Enfermo/complicaciones , Síndromes del Eutiroideo Enfermo/fisiopatología , Femenino , Infecciones por VIH/complicaciones , Humanos , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Testosterona/sangre
11.
Pathol Biol (Paris) ; 38(5 ( Pt 2)): 548-51, 1990 Jun.
Artículo en Francés | MEDLINE | ID: mdl-2385453

RESUMEN

We evaluated the efficacy and toxicity of piperacillin-ofloxacin as an empiric treatment of fever in patients with neutropenia. 24 febrile episodes occurring in 21 patients (mean neutropenia: 204/mm3) were treated. The neutropenia was due to an hematologic malignancy in 6 cases and to chemotherapy in 15 cases. Fever was related to septicemia in 4 cases, urinary tract infection in 1 case, other infectious sites without microbiological documentation in 11 cases, and was of unknown origin in 8 cases. Empirical therapy was started within 24 hours of the occurrence of fever greater than 38.5 degrees C with the combination of intravenous piperacillin (12 g/day in 3 divided doses) and oral ofloxacin (400 mg/day in 2 doses). The overall response rate was 86% (19/22) of evaluable cases, with an immediate success rate (apyrexia within 48 hours) of 46%. Of the 3 failures, one was bacteriologically documented and was due to a multiply resistant strain of Staphylococcus haemolyticus (to which both piperacillin and ofloxacin were resistant). The therapy was clinically well tolerated in all except 3 patients, in whom intolerance to intravenous piperacillin was observed, leading to discontinuation of the drug in 2 cases. More extensive and comparative trials should better determine the place of this piperacillin-ofloxacin combination as first-line treatment of febrile episodes in patients with neutropenia.


Asunto(s)
Agranulocitosis/complicaciones , Fiebre/tratamiento farmacológico , Ofloxacino/uso terapéutico , Piperacilina/uso terapéutico , Adulto , Anciano , Anciano de 80 o más Años , Agranulocitosis/epidemiología , Infecciones Bacterianas/complicaciones , Infecciones Bacterianas/tratamiento farmacológico , Infecciones Bacterianas/epidemiología , Quimioterapia Combinada , Femenino , Fiebre/epidemiología , Fiebre/etiología , Humanos , Masculino , Persona de Mediana Edad , Estudios Prospectivos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA